Confido Health Adds $12.5M Series A Extension for CareOS
Justin Saks is joining Confido Health from a career investing in multi-site healthcare, a useful vantage point for a startup selling into provider portfolios. The New York company announced a $12.5M Series A extension led by Z47 on October 14, 2026, taking its total Series A to $22.5M. Together Fund and Blume Ventures also participated, while Saks joined as an investor and board advisor.
The capital supports CareOS, Confido Health's platform for connecting administrative work across a practice's existing systems. Co-founders Chetan Reddy, CEO, and Vichar Shroff, CPO, are widening the company's voice-agent business into workflows that carry information from patient intake into later outreach, scheduling and payment follow-up. The commercial opportunity sits inside organizations that can share an owner while running different software and operating routines.
What the Series A Extension Changes
Confido Health's October announcement puts $12.5M of additional financing behind that broader product scope. The $22.5M figure describes the combined Series A, including the $10M round announced on September 30, 2025. Using the larger figure as the new extension would overstate the incremental capital arriving in this announcement.
Blume Ventures led the original Series A, whose company-issued release reported $13M in total funding at that time. An earlier $3M seed, announced in December 2024, was led by Together Fund. Those disclosures establish a financing history; the current release does not supply a new consolidated lifetime-funding figure or valuation.
Z47's portfolio materials place Confido Health within its AI and enterprise investments. The extension backs a company seeking a larger role in practice operations, with Saks adding experience around the organizations it wants to serve. Neither his advisor appointment nor the investor roster establishes that every practice in a sponsor's portfolio will adopt the product.
For Reddy and Shroff, expanding the assignment also expands the implementation work. A voice interaction can lead into another administrative task, and the result must remain useful to the team receiving it. More capital gives Confido resources to develop that connected workflow without making each clinic's local rules disappear.
Selling Through the Owner, Working Inside the Practice
Confido Health describes a distribution model that starts with private equity investors and reaches their provider companies through introductions after results are demonstrated. That sequence matters commercially: a successful deployment can give the supplier access to additional operating businesses through an established relationship. The introduction carries trust earned elsewhere, while the next practice brings its own requirements.
A multi-site group's purchasing team may want consistent patient access, staff capacity and collections across locations. The people implementing the system have a more detailed assignment: preserve the appointment rules, referral paths and exceptions that allow each location to operate. A shared purchasing relationship can help arrange that work, but it cannot supply knowledge nobody has documented.
Confido's approach lets the company sell a broader operating result while entering through familiar tasks such as patient calls. The logic is attractive for a supplier because the initial conversation has somewhere to go after one workflow works. For a practice manager, useful expansion means fewer handoffs to chase and a reliable way to see what happened to a patient's request.
That is an interpretation of the distribution model, rather than a forecast of revenue or guaranteed portfolio penetration. Confido Health has not disclosed retention, investor-by-investor customer conversion or the economics of deploying CareOS across an entire sponsor portfolio. Operators evaluating the product still need evidence from their own workflows, with local staff involved in deciding what software can complete and what needs human attention.
CareOS Has to Carry the Work Across Systems
Confido Health presents CareOS as the layer that connects patient information with the administrative action that follows. Its integration materials describe connections to EHRs, practice-management platforms, phone systems and other existing tools. The current company announcement reports more than 50 integrations, allowing provider groups to adopt the software while retaining their technology stack.
Keeping those systems in place changes the implementation proposition. A practice can consider automating more work without simultaneously undertaking a replacement of the software its staff already uses. The practical question becomes how accurately the agent reads the relevant record, applies the practice's rules and writes the completed task back into the right place.
Commercial partner Cekura describes Confido's testing of branching conversations and downstream tool calls. Its case study discusses simulated workflows and checks for behavior under timeouts, partial data and retries. That account is vendor-published evidence, but it offers a more concrete view of the engineering assignment than a polished call demonstration alone.
For example, a scheduling conversation needs an available appointment to become a stored booking that staff can use. A successful spoken exchange can leave work unfinished if the underlying tool call fails or the record changes incorrectly. As CareOS reaches further into the back office, the connection between a conversation and its administrative result becomes part of the product the practice is buying.
Reading the Customer Evidence Without Losing the Patient
Confido Health's Dallas Renal Group customer story describes phone volume interrupting staff who were also caring for people in front of them. The account names COO Srinivas Danda and explains how automated handling and routing changed the calls reaching staff. It is a company-published customer account, useful for understanding the operating problem rather than a universal forecast for another clinic.
The financing release also includes a statement from Vision Innovation Partners CFO Michael Pascetta that collections doubled after Confido's deployment. The company supplies no independently audited comparison or measurement window alongside that statement. Its value as evidence is the named customer's account of a specific workflow, with the attribution kept attached.
Related Suki financing coverage describes a different healthcare AI assignment centered on clinicians and clinical information. Confido Health concentrates on administrative work around access and practice operations. For healthcare buyers, identifying which part of the organization a product serves is more useful than treating every AI financing as the same competition.
The extension brings Confido further into work whose results patients experience as answered calls, completed bookings and follow-up that reaches the right person. Reddy and Shroff have a sponsor channel capable of opening more doors; behind each door, staff will still need CareOS to understand how that practice takes care of its administrative work while people are waiting.
Healthcare AI funding, last 30 days
DevCuration's funding database tracked 19 Healthcare AI rounds totaling $805.5M in disclosed capital over the past 30 days. Recent deals we covered:
- Suki Raises $90M Series E Financing for Healthcare AISeries E · $90M · Oct 14
- Collective X Health Raises $3.2M for Women's Health DataPre-Seed · $3.2M · Oct 14
- Intake AI Raises $2.5M for Clinical Trial OperationsPre-Seed · $2.5M · Oct 14
- Brellium Raises $23M for CortexLM and Specialty Expansion$23M · Oct 13
- Sensydia Raises Over $6M to Advance Cardiac AssessmentInitial Closing · More than $6M · Oct 13
Frequently Asked Questions
How does the $12.5M extension relate to Confido Health’s $22.5M Series A?
The October 14, 2026 announcement adds a $12.5M extension to the $10M Series A announced in September 2025. The combined Series A is $22.5M; the larger number is not the incremental amount of the extension.
Why does Confido Health sell through private equity investors?
Confido Health says it reaches provider portfolios through investor introductions after demonstrating results. This can create a path into additional multi-site practices, while each deployment still needs the local workflows and rules configured.
What administrative work is CareOS intended to connect?
CareOS carries information from patient intake into tasks such as outreach, scheduling and payment follow-up. Confido Health says it integrates with existing systems rather than requiring practices to replace their technology stack.
What do the customer examples establish about CareOS?
The Dallas Renal Group story describes staff call-routing pressure, and Vision Innovation Partners reports improved collections. These are attributed, company-published accounts; they do not establish a universal outcome for every practice.
Who is responsible for Confido Health’s expanded operating product?
Chetan Reddy is Confido Health’s co-founder and CEO, and Vichar Shroff is co-founder and CPO. Z47 led the extension, Together Fund and Blume Ventures participated, and Justin Saks joined as an investor and board advisor.
Where the Money Moved
The intelligence briefing of the innovation economy. Funding, M&A, debt and fund closes, read as market signal rather than deal announcements.
Subscribe to Where the Money Moved
